Akero Therapeutics, Inc. Earnings Per Share (Diluted)
Akero Therapeutics, Inc. reported Earnings Per Share (Diluted) of -$0.99 per share for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-07.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2025-11-07
- Akero Therapeutics, Inc. earnings per share, diluted for the quarter ending 2025-09-30 was -$0.99.
- Akero Therapeutics, Inc. earnings per share, diluted for the quarter ending 2025-06-30 was -$0.86.
- Akero Therapeutics, Inc. earnings per share, diluted for the quarter ending 2025-03-31 was -$0.90.
- Akero Therapeutics, Inc. earnings per share, diluted for the quarter ending 2024-12-31 was -$0.99.
- Akero Therapeutics, Inc. earnings per share, diluted for fiscal 2024 was -$3.75.
- Akero Therapeutics, Inc. earnings per share, diluted for fiscal 2023 was -$2.89.
- Akero Therapeutics, Inc. earnings per share, diluted for fiscal 2022 was -$2.87.
- Akero Therapeutics, Inc. earnings per share, diluted for fiscal 2021 was -$2.89.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|
| 2025-09-30 | -$0.99 10-Q · filed 2025-11-07 | -$1.86 derived: net income ÷ weighted average shares · filed 2025-11-07 | -$2.76 10-Q · filed 2025-11-07 | -$3.74 derived: net income ÷ weighted average shares · filed 2025-11-07 |
| 2025-06-30 | -$0.86 10-Q · filed 2025-08-08 | -$1.76 10-Q · filed 2025-08-08 | -$2.74 derived: net income ÷ weighted average shares · filed 2025-11-07 | -$3.78 derived: net income ÷ weighted average shares · filed 2025-11-07 |
| 2025-03-31 | -$0.90 10-Q · filed 2025-05-12 | -$1.89 derived: net income ÷ weighted average shares · filed 2025-11-07 | -$2.93 derived: net income ÷ weighted average shares · filed 2025-11-07 | -$3.74 derived: net income ÷ weighted average shares · filed 2025-11-07 |
| 2024-12-31 | -$0.99 derived: net income ÷ weighted average shares · filed 2025-11-07 | -$2.04 derived: net income ÷ weighted average shares · filed 2025-11-07 | -$2.85 derived: net income ÷ weighted average shares · filed 2025-11-07 | -$3.75 10-K · filed 2025-02-28 |
| 2024-09-30 | -$1.05 10-Q · filed 2025-11-07 | -$1.86 derived: net income ÷ weighted average shares · filed 2025-11-07 | -$2.76 10-Q · filed 2025-11-07 | -$3.74 derived: net income ÷ weighted average shares · filed 2025-11-07 |
| 2024-06-30 | -$0.81 10-Q · filed 2025-08-08 | -$1.70 10-Q · filed 2025-08-08 | -$2.68 derived: net income ÷ weighted average shares · filed 2025-11-07 | -$3.41 derived: net income ÷ weighted average shares · filed 2025-11-07 |
| 2024-03-31 | -$0.90 10-Q · filed 2025-05-12 | -$1.89 derived: net income ÷ weighted average shares · filed 2025-11-07 | -$2.60 derived: net income ÷ weighted average shares · filed 2025-11-07 | -$3.22 derived: net income ÷ weighted average shares · filed 2025-11-07 |
| 2023-12-31 | -$0.99 derived: net income ÷ weighted average shares · filed 2025-11-07 | -$1.70 derived: net income ÷ weighted average shares · filed 2025-11-07 | -$2.31 derived: net income ÷ weighted average shares · filed 2025-11-07 | -$2.89 10-K · filed 2025-02-28 |
| 2023-09-30 | -$0.71 10-Q · filed 2024-11-08 | -$1.32 derived: net income ÷ weighted average shares · filed 2024-11-08 | -$1.87 10-Q · filed 2024-11-08 | -$2.38 derived: net income ÷ weighted average shares · filed 2025-02-28 |
| 2023-06-30 | -$0.60 10-Q · filed 2024-08-09 | -$1.15 10-Q · filed 2024-08-09 | -$1.65 derived: net income ÷ weighted average shares · filed 2025-02-28 | -$2.51 derived: net income ÷ weighted average shares · filed 2025-02-28 |
| 2023-03-31 | -$0.55 10-Q · filed 2024-05-10 | -$1.04 derived: net income ÷ weighted average shares · filed 2025-02-28 | -$1.91 derived: net income ÷ weighted average shares · filed 2025-02-28 | -$2.67 derived: net income ÷ weighted average shares · filed 2025-02-28 |
| 2022-12-31 | -$0.49 derived: net income ÷ weighted average shares · filed 2025-02-28 | -$1.37 derived: net income ÷ weighted average shares · filed 2025-02-28 | -$2.13 derived: net income ÷ weighted average shares · filed 2025-02-28 | -$2.87 10-K · filed 2025-02-28 |
| 2022-09-30 | -$0.92 10-Q · filed 2023-11-13 | -$1.70 derived: net income ÷ weighted average shares · filed 2023-11-13 | -$2.45 10-Q · filed 2023-11-13 | -$3.37 derived: net income ÷ weighted average shares · filed 2024-02-29 |
| 2022-06-30 | -$0.77 10-Q · filed 2023-08-11 | -$1.52 10-Q · filed 2023-08-11 | -$2.45 derived: net income ÷ weighted average shares · filed 2024-02-29 | -$3.15 derived: net income ÷ weighted average shares · filed 2024-02-29 |
| 2022-03-31 | -$0.74 10-Q · filed 2023-05-15 | -$1.67 derived: net income ÷ weighted average shares · filed 2024-02-29 | -$2.37 derived: net income ÷ weighted average shares · filed 2024-02-29 | -$3.20 derived: net income ÷ weighted average shares · filed 2024-02-29 |
| 2021-12-31 | -$0.93 derived: net income ÷ weighted average shares · filed 2024-02-29 | -$1.63 derived: net income ÷ weighted average shares · filed 2024-02-29 | -$2.46 derived: net income ÷ weighted average shares · filed 2024-02-29 | -$2.89 10-K · filed 2024-02-29 |
| 2021-09-30 | -$0.70 10-Q · filed 2022-11-04 | -$1.53 derived: net income ÷ weighted average shares · filed 2022-11-04 | -$1.96 10-Q · filed 2022-11-04 | |
| 2021-06-30 | -$0.83 10-Q · filed 2022-08-05 | -$1.27 10-Q · filed 2022-08-05 | ||
| 2020-12-31 | -$2.52 10-K · filed 2022-02-25 | |||
| 2019-12-31 | -$2.90 10-K · filed 2022-02-25 |